Published in Br J Med Med Res on January 01, 2011
Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options. J Clin Exp Hepatol (2014) 0.84
Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension. Hepatology (2016) 0.78
Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran. Hepat Mon (2016) 0.75
Idiopathic noncirrhotic portal hypertension: current perspectives. Hepat Med (2016) 0.75
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med (1978) 11.42
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS (2007) 3.25
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis (2009) 2.78
Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol (2007) 1.77
Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr (2006) 1.49
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther (2008) 1.12
Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol (2008) 1.06
Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS (2009) 1.03
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS (2010) 0.99
Non-cirrhotic intrahepatic portal hypertension: A long term follow-up study. Q J Med (1981) 0.97
The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. J Hepatol (2010) 0.95
Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol (2009) 0.93
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients. Ann Hepatol (2009) 0.88
Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature. AIDS Patient Care STDS (2010) 0.86
Noncirrhotic portal hypertension in HIV infection. Curr Opin Infect Dis (2011) 0.84
Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect? AIDS (2007) 0.84
Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS (2007) 0.83
Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'. AIDS (2007) 0.82
Noncirrhotic portal hypertension and didanosine: a re-analysis. Clin Infect Dis (2011) 0.81
Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients. HIV Clin Trials (2009) 0.80
Abacavir and increased risk of myocardial infarction. Lancet (2008) 0.79
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology (2012) 1.89
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology (2013) 1.78
A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients. J Acquir Immune Defic Syndr (2007) 1.76
Desert dust exposure is associated with increased risk of asthma hospitalization in children. Am J Respir Crit Care Med (2010) 1.69
Examination of sources of diagnostic error leading to cervical cone biopsies with no evidence of dysplasia. Am J Clin Pathol (2013) 1.38
Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS (2006) 1.37
Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies. Ann Diagn Pathol (2013) 1.23
Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics (2008) 1.10
Burden of disease associated with overweight and obesity among U.S. military retirees and their dependents, aged 38-64, 2003. Prev Med (2004) 1.07
Association between obesity and depressive symptoms among U.S. Military active duty service personnel, 2002. J Psychosom Res (2006) 1.04
Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model. AIDS Res Ther (2013) 1.01
Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol (2014) 0.96
Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older. J Manag Care Pharm (2007) 0.95
TAMIS-assisted laparoscopic low anterior resection with total mesorectal excision in a cadaveric series. Surg Endosc (2013) 0.91
Effects of maternal characteristics on cesarean delivery rates among U.S. Department of Defense healthcare beneficiaries, 1996-2002. Birth (2004) 0.91
Clinical case mix adjustment of cesarean delivery rates in U.S. military hospitals, 2002. Obstet Gynecol (2005) 0.89
A comparison in HIV-associated stigma among healthcare workers in urban and rural Gujarat. SAHARA J (2010) 0.88
Effect of preexisting chronic disease on primary cesarean delivery rates by race for births in U.S. military hospitals, 1999-2002. Birth (2004) 0.87
Efavirenz--still first-line king? Expert Opin Drug Metab Toxicol (2008) 0.86
Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment. AIDS Res Ther (2011) 0.85
Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofungin. Clin Infect Dis (2004) 0.85
Childbearing in U.S. military hospitals: dimensions of care affecting women's perceptions of quality and satisfaction. Birth (2005) 0.85
Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery. AIDS (2010) 0.85
Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications. J Acquir Immune Defic Syndr (2016) 0.81
Unusual imaging profile of a solitary splenic lymphangioma. Acta Radiol Short Rep (2012) 0.81
Pancreatic rest resection using band ligation snare polypectomy. Dig Dis Sci (2011) 0.80
A new liver explant fixation technique. Arch Pathol Lab Med (2008) 0.80
Denial of risk behavior does not exclude asymptomatic anorectal sexually transmitted infection in HIV-infected men. PLoS One (2009) 0.80
Heavy Alcohol Use Is Associated With Worse Retention in HIV Care. J Acquir Immune Defic Syndr (2016) 0.80
Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons. AIDS Care (2014) 0.79
Relative accuracy of cervical and anal cytology for detection of high grade lesions by colposcope guided biopsy: a cut-point meta-analytic comparison. PLoS One (2012) 0.79
Abacavir and increased risk of myocardial infarction. Lancet (2008) 0.79
CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited. J Infect Dis (2005) 0.79
Status of U.S. military retirees and their spouses toward achieving Healthy People 2010 objectives. Am J Health Promot (2006) 0.78
Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr (2013) 0.78
High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen. AIDS (2013) 0.78
Utility of clinical assessment, imaging, and cryptococcal antigen titer to predict AIDS-related complicated forms of cryptococcal meningitis. AIDS Res Ther (2010) 0.78
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study. J Acquir Immune Defic Syndr (2016) 0.78
Short communication: lack of occult HIV infection among non-AIDS-defining cancer patients in three academic oncology clinics in the United States. AIDS Res Hum Retroviruses (2013) 0.77
Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replication. J Acquir Immune Defic Syndr (2009) 0.77
Two-dimensional electron system in high magnetic fields: Wigner crystal versus composite-fermion liquid. Phys Rev Lett (2003) 0.77
Effect of September 11th terrorist attacks on the self-reported health status of Department of Defense health care beneficiaries. Mil Med (2004) 0.77
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population. J Acquir Immune Defic Syndr (2017) 0.76
Schistosomiasis and signet ring cell carcinoma of the rectum. Ann Diagn Pathol (2011) 0.76
Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012. J Acquir Immune Defic Syndr (2017) 0.75
Respiratory symptoms necessitating spirometry among soldiers with Iraq/Afghanistan war lung injury. J Occup Environ Med (2011) 0.75
Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue. J Acquir Immune Defic Syndr (2016) 0.75
Human H5N1 influenza. N Engl J Med (2007) 0.75
Amphicrine carcinoma of the liver. Ann Diagn Pathol (2010) 0.75
The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care. J Acquir Immune Defic Syndr (2017) 0.75
Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use. AIDS (2006) 0.75
Expanding your laboratory by accessing collaboratory resources. Anal Bioanal Chem (2004) 0.75
Reconstructing the electron in a fractionalized quantum fluid. Phys Rev Lett (2005) 0.75
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrations. Clin Infect Dis (2006) 0.75
Strong correlations produce the Curie-Weiss phase of NaxCoO2. Phys Rev Lett (2006) 0.75
The hydraulic squeegee: a novel and simple method for removing silicone oil from an intraocular lens. Retina (2009) 0.75
Gonococcal meningitis diagnosed by DNA amplification: case report and review of the literature. AIDS Patient Care STDS (2007) 0.75